Literature DB >> 7378237

Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia.

F Okumura, B D Crocker, M A Denborough.   

Abstract

In vitro studies, using agents which act specifically on different parts of the muscle contractile mechanism, suggest that the abnormality in malignant hyperpyrexia susceptible (MHS) swine muscle lies distal to the postjunctional membrane, and that it is not a result of widespread acetylcholine receptors throughout the muscle membrane. Two possible sites are involved, one being the sarcolemma and the T-system, the other the excitation-contraction coupling mechanism and the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378237     DOI: 10.1093/bja/52.4.377

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

Review 1.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

2.  Halothane induced vasomotion of coronary, renal and iliac arterial rings in malignant hyperthermia susceptible swine.

Authors:  L DeRoth; S Nadeau; H Héon
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

Review 3.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

4.  Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.

Authors:  Wenqian Chen; Andrea Koop; Yingjie Liu; Wenting Guo; Jinhong Wei; Ruiwu Wang; David H MacLennan; Robert T Dirksen; Sui Rong Wayne Chen
Journal:  Biochem J       Date:  2017-08-07       Impact factor: 3.857

5.  Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.

Authors:  B A Britt; E Scott; W Frodis; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1984-03

Review 6.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

7.  Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.

Authors:  Dawei Jiang; Wenqian Chen; Jianmin Xiao; Ruiwu Wang; Huihui Kong; Peter P Jones; Lin Zhang; Bradley Fruen; S R Wayne Chen
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

8.  Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

Authors:  B A Britt; W Frodis; E Scott; M J Clements; L Endrenyi
Journal:  Can Anaesth Soc J       Date:  1982-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.